Cervical cancer diagnosis and treatment delays in the developing world: Evidence from a hospital-based study in Zambia.
Cancer Diseases Hospital
Cervical cancer
Public health facility
Screening
Turnaround time
Journal
Gynecologic oncology reports
ISSN: 2352-5789
Titre abrégé: Gynecol Oncol Rep
Pays: Netherlands
ID NLM: 101652231
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
18
03
2021
revised:
18
04
2021
accepted:
30
04
2021
entrez:
7
6
2021
pubmed:
8
6
2021
medline:
8
6
2021
Statut:
epublish
Résumé
Expedited diagnostic processes for all suspected cervical cancer cases remain essential in the effort to improve clinical outcomes of the disease. However, in some developing countries like Zambia, there is paucity of data that assesses factors influencing diagnostic and treatment turnaround time (TAT) and other metrics vital for quality cancer care. We conducted a retrospective hospital-based study at the Cancer Diseases Hospital (CDH) for cervical cancer cases presenting to the facility between January 2014 and December 2018. Descriptive statistics were used to summarize demographic characteristics while a generalized linear model of the negative binomial was used to assess determinants of overall TAT. Our study included 2121 patient case files. The median age was 49 years (IQR: ±17) and most patients (n = 634, 31%) were aged between 41 and 50 years. The International Federation of Gynaecology and Obstetrics (FIGO) Cancer stage II (n = 941, 48%) was the most prevalent while stage IV (n = 103, 5.2%) was the least. The average diagnostic TAT in public laboratories was 1.48 (95%CI: 1.21-1.81) times longer than in private laboratories. Furthermore, referral delay was 55 days (IQR: 24-152) and the overall TAT (
Identifiants
pubmed: 34095422
doi: 10.1016/j.gore.2021.100784
pii: S2352-5789(21)00088-6
pmc: PMC8165546
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100784Informations de copyright
© 2021 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Rev Saude Publica. 2015;49:
pubmed: 26786473
Methods Inf Med. 2005;44(1):4-10
pubmed: 15778788
Health Serv Res. 2011 Dec;46(6pt2):2079-100
pubmed: 21762144
Zhonghua Yu Fang Yi Xue Za Zhi. 2014 May;48(5):366-9
pubmed: 24985374
Gut. 2015 Mar;64(3):381-7
pubmed: 25320104
BMC Health Serv Res. 2019 Jul 2;19(1):443
pubmed: 31266482
Am J Clin Pathol. 2014 Oct;142(4):541-5
pubmed: 25239422
Acad Emerg Med. 2008 Nov;15(11):1130-5
pubmed: 18638034
Glob Health Sci Pract. 2019 Mar 13;7(Suppl 1):S68-S84
pubmed: 30867210
BMC Public Health. 2018 Oct 3;18(1):1156
pubmed: 30285699
Int J Cancer. 2000 May 1;86(3):429-35
pubmed: 10760834
Niger J Med. 2008 Apr-Jun;17(2):186-90
pubmed: 18686837
Climacteric. 2018 Jun;21(3):235-238
pubmed: 29488817
Medicine (Baltimore). 2016 Aug;95(33):e4568
pubmed: 27537583
Gynecol Oncol. 2018 Apr;149(1):53-62
pubmed: 29605051
Can J Surg. 2006 Feb;49(1):16-21
pubmed: 16524138
Clin Oncol (R Coll Radiol). 2003 Apr;15(2):47-54
pubmed: 12708710
HIV Ther. 2010;4(6):703-722
pubmed: 25419240
Reprod Health Matters. 2008 Nov;16(32):41-9
pubmed: 19027621
Afr J Lab Med. 2020 Jun 03;9(1):974
pubmed: 32537426
Curr Probl Cancer. 2018 Sep;42(5):457-465
pubmed: 30064936
PLoS One. 2012;7(11):e48834
pubmed: 23155413
Br J Cancer. 2020 Jul;123(1):148-154
pubmed: 32336751
Obstet Gynecol Clin North Am. 2013 Jun;40(2):211-23
pubmed: 23732026
AIDS. 2003 Sep 5;17(13):1963-8
pubmed: 12960829
Cancer Res. 2019 Mar 15;79(6):1252-1259
pubmed: 30635276
Int J Biol Sci. 2019 Sep 7;15(11):2438-2447
pubmed: 31595161
BMJ. 2000 Feb 19;320(7233):474-8
pubmed: 10678859
Bull World Health Organ. 2001;79(10):954-62
pubmed: 11693978
BMC Womens Health. 2016 Jun 04;16:29
pubmed: 27259656
Surg Endosc. 2021 Mar;35(3):1278-1287
pubmed: 32198552
BMC Health Serv Res. 2019 Apr 24;19(1):240
pubmed: 31014324
J Glob Oncol. 2017 Dec;3(6):734-739
pubmed: 29244984
PLoS One. 2019 Sep 4;14(9):e0221946
pubmed: 31483834
Virchows Arch. 2018 Jun;472(6):919-936
pubmed: 29725757
Expert Opin Investig Drugs. 2017 Apr;26(4):389-402
pubmed: 28274154
Semin Radiat Oncol. 2006 Jul;16(3):177-85
pubmed: 16814159
Lancet Glob Health. 2020 Feb;8(2):e191-e203
pubmed: 31812369
PLoS One. 2020 Apr 8;15(4):e0230858
pubmed: 32267844
J Womens Health (Larchmt). 2006 Oct;15(8):941-51
pubmed: 17087618
Clin Biochem Rev. 2007 Nov;28(4):179-94
pubmed: 18392122
Int J Gynecol Cancer. 2015 Jan;25(1):98-105
pubmed: 25423318
J Glob Oncol. 2015 Dec 23;2(1):4-8
pubmed: 28717676